Evolent Health, Inc. (EVH)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$4.32+1.41%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · EVH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 2,097.0 | 1,876.2 | 2,554.7 | 1,963.9 | 1,352.0 | 908.0 | 924.6 | 846.4 | 627.1 | — | — | — |
| Total Revenues | — | — | — | — | — | 908.0 | 924.6 | — | — | — | — | — |
| Cost of Revenues | 1,735.4 | 1,476.3 | 2,187.4 | 1,503.4 | 1,035.4 | 657.6 | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 291.9 | 303.9 | 263.1 | 358.1 | 269.3 | 219.5 | 210.4 | 236.4 | 235.4 | 205.7 | 160.7 | 75.3 |
| R&D Expenses | — | — | — | — | — | 15.5 | 15.1 | 19.8 | 18.2 | 17.2 | 11.1 | 5.8 |
| Other Operating Expenses, Total | — | — | — | — | — | (0.1) | (0.1) | (0.5) | 0.1 | 0.2 | 0.0 | 0.0 |
| Operating Income | (427.5) | (410.1) | (40.5) | (71.2) | 3.6 | (42.4) | (262.8) | (308.9) | (47.5) | (72.8) | (237.4) | (43.0) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | — | — | 54.2 | 15.6 | 25.4 | 28.3 | 14.6 | 5.5 | 3.6 | — | — |
| Interest & Investment Income | 3.5 | 4.2 | 5.5 | 5.3 | 1.4 | 0.4 | 2.6 | 3.4 | 3.4 | 1.7 | — | — |
| Net Interest Expenses | — | — | — | 48.9 | 14.2 | 25.0 | 25.7 | 11.1 | 2.0 | 2.0 | — | — |
| EBT, Incl. Unusual Items | — | (534.6) | (63.0) | (202.4) | (62.1) | (29.8) | (330.5) | (330.0) | (54.2) | (76.4) | (237.5) | 343.3 |
| Income Tax Expense | 2.9 | (0.1) | (1.4) | (89.4) | (43.4) | 0.5 | (2.4) | (22.8) | 0.0 | (6.6) | (10.8) | 23.5 |
| Earnings from Continuing Operations | — | — | — | — | — | (30.3) | (328.2) | — | — | — | — | — |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | — | — | 0.0 | 0.0 | (3.6) | (1.5) | (9.1) | (67.0) | (12.7) |
| Net Income | (505.0) | (534.5) | (61.6) | (142.3) | (19.2) | (37.6) | (334.2) | (302.0) | (52.7) | (60.7) | (159.7) | 332.5 |
| Per Share | ||||||||||||
| Basic EPS | (4.49) | (5.07) | (0.81) | (1.28) | (0.20) | (0.44) | (3.94) | — | — | (0.94) | (3.55) | 13.14 |
| Diluted EPS | (4.49) | (5.07) | (0.81) | (1.28) | (0.20) | (0.44) | (3.94) | — | — | (0.94) | (3.55) | 6.93 |
| Revenue per Share | 18.63 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 112.5 | 114.2 | 114.7 | 111.3 | 93.7 | 86.1 | 84.9 | — | — | 64.4 | 45.0 | 25.1 |
| Diluted Weighted Avg Shares | 112.5 | 114.2 | 114.7 | 111.3 | 93.7 | 86.1 | 84.9 | — | — | 64.4 | 45.0 | 46.1 |
| Supplemental | ||||||||||||
| EBITDA | — | (294.3) | 77.9 | 52.2 | 70.8 | 17.6 | (202.0) | (248.6) | (3.0) | (40.5) | (220.2) | (35.8) |
| EBIT | (427.5) | (410.1) | (40.5) | (71.2) | 3.6 | (42.4) | (262.8) | (308.9) | (47.5) | (72.8) | (237.4) | (43.0) |
| Effective Tax Rate | — | — | — | 44.2% | 69.9% | -1.6% | 0.7% | 6.9% | -0.1% | 8.7% | 4.5% | 6.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.